Because our previous experiment showed a significant decrease in %sO2 three hours after one dose of ITPP, we were particularly interested in whether this change in %sO2 was related to the immunogenicity of the tumor as primed by ITPP. The gene discussed is TPP1; the disease is neoplasm.